INTEGRATION OF END-OF-TREATMENT CIRCULATING TUMOR DNA WITH PET-CT IMPROVES RESPONSE ASSESSMENT IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Vincent Camus, 4206957

REDUCED CD20 EXPRESSION AND INTRATUMORAL CD3+ T CELLS FOLLOWING EPCORITAMAB TREATMENT ARE ASSOCIATED WITH PROGRESSIVE DISEASE IN A SUBSET OF DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA

EHA Library, Monica Wielgos-Bonvallet, 4206958

OUTCOMES BY LYMPHOMAP ARCHETYPES IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL

EHA Library, R. Andrew Harkins, 4206959

CHROMOSOME 8Q COPY NUMBER GAIN PREDICTS EARLY RELAPSE IN HIGH-GRADE DIFFUSE LARGE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS

EHA Library, Tom van den Bosch, 4206960

PHASE 3 INMIND TRIAL OF TAFASITAMAB (TAFA) PLUS LENALIDOMIDE (LEN) AND RITUXIMAB (R) IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): ANALYSES OF BIOMARKERS PREDICTIVE OF PATIENT (PT) RESPONSE

EHA Library, Diana Alvarez Arias, 4206964

RHOA IS ESSENTIAL FOR NPM-ALK-DRIVEN LYMPHOMAGENESIS AND REPRESENTS A PROMISING THERAPEUTIC TARGET IN ALK+ ALCL

EHA Library, Claudia Voena, 4206966

ASSOCIATION OF GERMLINE IEI GENE MUTATIONS WITH DISEASE SUBTYPES AND PROGNOSIS IN PEDIATRIC LYMPHOMA

EHA Library, Keyan Yang, 4206968

GENETIC ALTERATIONS IN PEDIATRIC B-CELL NON-HODGKIN LYMPHOMA IN PATIENTS WITH INBORN ERRORS OF IMMUNITY

EHA Library, Sara Mato, 4206969

PHARMACODYNAMIC BIOMARKERS SUPPORT THE CLINICAL BENEFIT OF EPCORITAMAB PLUS RITUXIMAB AND LENALIDOMIDE (R2) IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): ANALYSES FROM EPCORE FL-1

EHA Library, Lorenzo Falchi, 4206970

SINGLE-CELL RNA SEQUENCING REVEALS THE TUMOR MICROENVIRONMENT AND MOLECULAR FEATURES OF MALIGNANT T CELLS IN ADVANCED CUTANEOUS T-CELL LYMPHOMA

EHA Library, Jieting Wang, 4206972

RELAPSE IN PEDIATRIC ALK⁺ ALCL IS ASSOCIATED WITH EARLY INFLAMMATORY SIGNALING AND TUMOR MICROENVIRONMENT REMODELING

EHA Library, Rebekka Salzmann, 4206973

PATIENT-DERIVED LYMPHOMA SPHEROIDS AS PRECLINICAL MODELS FOR PREDICTING PATIENT RESPONSES TO ADVANCED THERAPIES IN B-NHL: EXAMPLE OF GLOFITAMAB IN FOLLICULAR LYMPHOMA

EHA Library, christine Bezombes, 4206974

CK2 INHIBITION REPROGRAMS THE EPIGENETIC LANDSCAPE AND ENHANCES SENSITIVITY TO TARGETED THERAPY IN GERMINAL CENTER DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Amir Yami, 4206975

AID INACTIVATION PROMOTES APOBEC-MEDIATED MUTAGENESIS IN GERMINAL CENTER LYMPHOMA

EHA Library, Sandrine Sander, 4206979

RITUXIMAB-MODIFIED MNO₂-COATED ZIF-8 NANOPLATFORM LOADED WITH DOXORUBICIN FOR TARGETED THERAPY OF B-CELL LYMPHOMA

EHA Library, Hao Yao, 4206980

INTEGRATED MOLECULAR AND METABOLIC PROFILING IDENTIFIES DETERMINANTS OF OUTCOME WITH LONCASTUXIMAB TESIRINE IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Ciro Maria Improta, 4206985

DURABLE RESPONSES WITH RONDECABTAGENE AUTOLEUCEL (DUAL-TARGETING CD19/CD20 CAR T-CELLS) ARE ASSOCIATED WITH HIGHER PROPORTION OF CYTOTOXIC T CELLS WITH MEMORY POTENTIAL IN INFUSION PRODUCTS

EHA Library, Akil Merchant, 4206986

INTEGRATIVE TRANSCRIPTOMIC PROFILING REVEAL THE MOLECULAR LANDSCAPE AND REGULATORY DRIVERS OF BLASTOID MANTLE CELL LYMPHOMA

EHA Library, Li Wang, 4206988

THE NEUROENDOCRINE-METABOLIC-IMMUNE AXIS IN B-CELL LYMPHOMA: ROLE OF ACBP/DBI IN GLUCOCORTICOID RESISTANCE AND IMMUNOSUPPRESSION

EHA Library, Hui PAN, 4206991

TARGETING RNF20 INHIBITS THE PROGRESSION OF DIFFUSE LARGE B-CELL LYMPHOMA THROUGH REGULATING UBIQUITINATION-DEPENDENT PHASE SEPARATION OF FUS

EHA Library, Qianqian Guo, 4206994

PROTEOLYSIS-TARGETING CHIMERA (PROTAC) TARGETING BRUTON TYROSINE KINASE (BTK) DEGRADATION IN MANTLE CELL LYMPHOMA

EHA Library, Xiaohui Wang, 4206996

PROLIFERATING TCF1LOW PD-1HIGH POPULATION IN HUMAN CD8+ T-CELLS IS ASSOCIATED WITH THE ONSET OF AGVHD AND SUPPRESSED BY PTCY

EHA Library, Kazuya Asano, 4207003

OUTCOME OF PATIENTS TREATED FOR T-ALL WITH HSCT IN THE FORUM COHORT

EHA Library, Jeanne Martin, 4207005

IMPACT OF DONOR AGE ON OUTCOMES OF ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC SEVERE APLASTIC ANEMIA

EHA Library, Jingyu Gao, 4207007

SUPERIOR OUTCOMES WITH B-LEADER-MATCHED HAPLOIDENTICAL VERSUS MATCHED SIBLING DONORS IN AL/MDS PATIENTS AGED ≥40 YEARS

EHA Library, Yujun Wei, 4207010

GENETIC ABNORMALITIES INFLUENCE THE PROGNOSTIC VALUE OF PRE-TRANSPLANT MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA: A MULTICENTRE STUDY

EHA Library, Yue Jin, 4207012

THE SAFETY AND EFFICACY OF BELUMOSUDIL AND RUXOLITINIB COMBINATION IN RUXOLITINIB REFRACTORY CGVHD

EHA Library, Yibo Wu, 4207014

HOSPITAL BASED OUTPATIENT DAILY DOSING MYELOABLATIVE INTRAVENOUS AND PHARMACOKINETICALLY GUIDED BUSULFAN BASED CONDITIONING FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT – SINGLE CENTER EXPERIENCE

EHA Library, Mathias Palmer, 4207016

RISK FACTORS AND PROGNOSTIC INDICATORS OF ACUTE RESPIRATORY FAILURE FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY

EHA Library, Xiaojin Wu, 4207018

IMMUNOSUPPRESSIVE STRATEGY USING LOW-DOSE ATG COMBINED WITH ANTI-CD25 ANTIBODY FOR GVHD PROPHYLAXIS IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiaosheng Fang, 4207020

IMPACT OF CONCURRENT GRAFT-VERSUS-HOST DISEASE ON LONG-TERM SURVIVAL IN CRITICALLY ILL PATIENTS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES

EHA Library, Zhixue Li, 4207021

ASSOCIATIONS OF AGE AND PRE-TRANSPLANT EMOTIONAL STATUS WITH EARLY IMMUNE RECONSTITUTION AFTER PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jiali Ma, 4207023

ROMIPLOSTIM N01 FOR PROMOTING PLATELET ENGRAFTMENT AFTER ALLO-HSCT: INTERIM RESULTS OF A PHASE II EXPLORATORY TRIAL FROM NICHE COHORT

EHA Library, Shan Jiang, 4207025

THE COMBINATION OF RUXOLITINIB AND EXTRACORPOREAL PHOTOPHERESIS IS A HIGHLY EFFECTIVE SECOND LINE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Andrea Varkonyi, 4207026

EXPLORATION OF A NOVEL AGVHD PROPHYLAXIS REGIMEN BASED ON GECACITINIB IN THE PERITRANSPLANT PERIOD OF PATIENTS WITH MYELOFIBROSIS: A PILOT OPEN-LABEL STUDY

EHA Library, Na Xu, 4207029

POST-TRANSPLANT ASCIMINIB TREATMENT AS MAINTENANCE, PRE-EMPTIVE OR RELAPSE THERAPY IN PHILADELPHIA-POSITIVE ADVANCED LEUKEMIAS: MULTICENTER REAL-WORLD DATA ANALYSIS

EHA Library, Mohamed Isam Sharif, 4207033

TREATED WITH EMAPALUMAB AS A BRIDGE TO HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY/RECURRENT EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Na Wei, 4207034

A PHASE II STUDY OF A BUSULFAN IN COMBINATION WITH FLAG CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETC STEM CELL TRANSPLANTATION

EHA Library, Xiawei Zhang, 4207035

ASSESSMENTS OF BONE HEALTH AMONG PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE RECEIVING AXATILIMAB IN THE AGAVE-201 TRIAL

EHA Library, Amandeep Salhotra, 4207040

PREDICTIVE VALUE OF EASIX SCORES AT DIFFERENT TIME POINTS FOR PTLD AND SURVIVAL IN PATIENTS WITH EBV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Luxin Yang, 4207042

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN OLDER ADULTS: CLINICAL OUTCOMES AND INNOVATIVE USE OF PRE-EMPTIVE DONOR LYMPHOCYTE INFUSIONS

EHA Library, Davide Stella, 4207045

MEASURABLE RESIDUAL DISEASE (MRD) EVALUATION AND OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNDERGOING THEIR SECOND ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Jule Ussmann, 4207047

TWO‑TUBE 12‑COLOR FLOW CYTOMETRY–BASED PRE‑TRANSPLANT IMMUNOPHENOTYPIC LSC‑MRD STRATIFIES RELAPSE RISK AND SURVIVAL AFTER ALLO‑HCT FOR AML

EHA Library, Tzu-Ting Chen, 4207048

HIGH EFFICACY AND MANAGEABLE SAFETY OF MARIBAVIR AS FIRST LINE TREATMENT FOR CMV INFECTION IN ALLO-HSCT RECIPIENTS: A MULTICENTER, RETROSPECTIVE, CONTROLLED COHORT STUDY

EHA Library, Jiaxin Cao, 4207051

EVALUATION OF THE EAM CONDITIONING REGIMEN IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HODGKIN LYMPHOMA

EHA Library, Amal Bendimerad, 4207053

STUDY ON THE EFFECTS OF ENHANCED IMMUNE-NUTRIENT INTERVENTION IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xueqian Yan, 4207055

SPATIAL PROFILING OF T CELL SUBSETS REVEALS DISTINCT IMMUNE MICROENVIRONMENT PATTERNS ASSOCIATED WITH SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Filippa Wikström, 4206955

GENOMIC AND TRANSCRIPTOMIC LANDSCAPE OF FOLLICULAR LYMPHOMA

EHA Library, Matin Salehi, 4206956

BRIGATINIB RESISTANCE IN PEDIATRIC ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA IS DRIVEN BY GPX4-MEDIATED FERROPTOSIS SUPPRESSION

EHA Library, Gerardo Enrique Abarca Ríos, 4206961

THE STRESS-SENSING MARCH5 AXIS GOVERNS BLOOD CANCER APOPTOTIC RESILIENCE VIA TRACTABLE PROTEIN–PROTEIN INTERACTIONS

EHA Library, Thomas Lew, 4206962

GENOMIC ARCHITECTURE OF IRF4 REARRANGEMENTS IN CHILDREN AND ADULT LARGE B-CELL LYMPHOMAS

EHA Library, Ariadna Colmenero, 4206963

INTEGRATED SNV/CNV PROFILING AT DIAGNOSIS IN MANTLE CELL LYMPHOMA IDENTIFIES GENOMIC CORRELATES OF CLINICAL HETEROGENEITY AND OUTCOME

EHA Library, Jana Karolová, 4206965

PD-L1 AMPLIFICATION BUILDS AN IMMUNE FORTRESS IN EBV+ DLBCL: SPATIAL MULTI-OMICS REVEALS PHYSICAL T-CELL EXCLUSION ALONGSIDE FUNCTIONAL SUPPRESSION

EHA Library, Axel Künstner, 4206967

LONGITUDINAL SINGLE-CELL ANALYSIS REVEALS CLONAL EVOLUTION AND THERAPEUTIC RESISTANCE IN LYMPHOMA ASSOCIATED WITH INBORN ERROR OF IMMUNITY

EHA Library, Hui Wan, 4206971

INTEGRATIVE MULTI-OMICS FRAMEWORK IDENTIFIES TGFB1–CXCL12 SIGNALING AS A CONSERVED IMMUNOREGULATORY NETWORK IN HIGH-GRADE B-CELL LYMPHOMA AND REACTIVE LYMPHOID TISSUES

EHA Library, Keisuke Kidoguchi, 4206976

PRETREATMENT CTDNA-BASED RISK PREDICTION IN DLBCL: PANEL-INDEPENDENT COPY-NUMBER ANALYSIS OVERCOMES INTER-ASSAY THRESHOLD VARIABILITY

EHA Library, Rebecca Goodhew, 4206978

PATIENTS WITH T CELLS MAINTAINING AN IMMUNE SIGNATURE FEATURING EARLY DIFFERENTIATION STAGE EXHIBIT A SUPERIOR CLINICAL RESPONSE TO PEMBROLIZUMAB IN RELAPSED LOW-GRADE LYMPHOMA

EHA Library, Zhi-Zhang Yang, 4206981

TARGETING HELLS-MCM5 AXIS TO EXPLOIT TRANSCRIPTION-REPLICATION CONFLICTS AS NOVEL THERAPEUTIC STRATEGY IN ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Valentina Fragliasso, 4206983

DIOSCIN INHIBITS DIFFUSE LARGE B-CELL LYMPHOMA BY MODULATING ACACA-DEPENDENT HISTONE H3K27 ACETYLATION AND INDUCING MITOPHAGY

EHA Library, Qianqian Guo, 4206984

TAXONOMIC AND FUNCTIONAL INTESTINAL MICROBIOME PROFILES DISTINGUISH MANTLE CELL LYMPHOMA PATIENTS FROM CONTROLS AND PERSIST ACROSS DISEASE STATES

EHA Library, Justin Desroches, 4206987

CLINICAL AND MOLECULAR CHARACTERISTICS AND THEIR IMPACT ON PROGNOSIS IN CHINESE PEDIATRIC MATURE B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Qinlong Zheng, 4206989

WHOLE-GENOME SEQUENCING REVEALS DISTINCT MOLECULAR CLASSIFICATION PATTERNS IN DIFFUSE LARGE B-CELL LYMPHOMA IN CHINESE PATIENTS

EHA Library, Mingyu Yang, 4206990

CLONAL COMPLEXITY DEFINES DISTINCT TUMOR-INTRINSIC BIOLOGY AND PROGNOSIS IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Takahiro Haeno, 4206993

PHASED VARIANTS REVEAL PROTO-ONCOGENE PROMOTER HYPERMUTATION AND CFDNA FRAGMENTATION PATTERNS IN DLBCL

EHA Library, Luca Varga, 4206995

ALLOGENEIC TRANSPLANTATION: DISEASE RESPONSE AND COMPARATIVE TREATMENT STUDIES

EHA Library, xiaodong lyu, 4206997

ALLOGENEIC HSC TRANSPLANTATION INCREASES ACETYLCHOLINE PRODUCTION BY DONOR-DERIVED LYMPHOCYTES, WHICH RESTRAINS T CELL ACTIVATION AND EXPANSION VIA ALPHA7 NICOTINIC RECEPTOR - IMPLICATIONS FOR GVHD

EHA Library, Jose Antonio Bejarano Garcia, 4206998

CLONAL DYNAMICS OF THE TCRΒ REPERTOIRE REVEAL PREDICTIVE IMMUNE SIGNATURES OF POST-TRANSPLANT COMPLICATIONS

EHA Library, xiaodong lyu, 4206999

CIRCULATING MICRORNA SEQUENCING REVEALS CONSISTENT EXPRESSION DYNAMICS ACROSS MOBILIZATION STRATEGIES AND PREDICTIVE MARKERS OF EFFICACY IN MULTIPLE MYELOMA PATIENTS

EHA Library, Damian Mikulski, 4207000

EPIGENETIC MODULATION ENABLES EXPANSION OF FUNCTIONAL HUMAN HSPCS IN A CHEMICALLY DEFINED SYSTEM FOR CELL AND GENE CLINICAL APPLICATIONS

EHA Library, Nobuchika Yamamoto, 4207001

EARLIER EMERGENCE OF PROLIFERATIVE CD8+ T CELLS IS ASSOCIATED WITH IMPROVED PROGNOSIS IN R/R DLBCL PATIENTS TREATED WITH AUTO-HSCT PLUS UMBILICAL CORD BLOOD INFUSION

EHA Library, Zhengchang He, 4207002

IMPACT OF EARLY POST-TRANSPLANT MEASURABLE RESIDUAL DISEASE ON OUTCOMES OF PATIENTS WITH RELAPSED/ REFRACTORY AML: A POST-HOC ANALYSIS OF THE PROSPECTIVE ASAP TRIAL

EHA Library, Katharina Egger-Heidrich, 4207004

ROMIPLOSTIM N01 FOR PLATELET RECOVERY AFTER UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: A PHASE II, SINGLE-ARM STUDY

EHA Library, Wanjie Wang, 4207006

PHASE II STUDY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH AUTOLOGOUS CD19-CAR T CELL INFUSION IN ADULTS WITH HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL OUTCOMES

EHA Library, Rongli Zhang, 4207008

LONG-TERM EFFICACY AND SAFETY OF DONOR-DERIVED CAR-T CELLS INTEGRATED INTO ALLOGENEIC HSCT CONDITIONING FOR ULTRA-HIGH-RISK R/R B-NHL, T-LBL, AND MULTIPLE MYELOMA: A 5-YEAR FOLLOW-UP STUDY

EHA Library, Fan Yang, 4207009

INTEGRATING IMS–IMWG GENOMIC RISK WITH R2-ISS IMPROVES RISK STRATIFICATION IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA

EHA Library, Oren Pasvolsky, 4207011

THIOTEPA-FLUDARABINE-TREOSULFAN VS THIOTEPA-FLUDARABINE-BUSULFAN IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ADULT AML PATIENTS IN CR. A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT.

EHA Library, Enrico Maffini, 4207015

RESPIRATORY TRACT INVASIVE FUNGAL INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE IN AML AND MDS: A  STUDY CONDUCTED ON BEHALF OF GETH-TC

EHA Library, Maria Queralt Salas, 4207017

CPX-351 BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION, A REAL-WOLRD FRENCH EXPERIENCE

EHA Library, Eléonore Kaphan, 4207019

BURDEN, SPECTRUM, AND PROGNOSTIC IMPACT OF INFECTIONS AFTER ALLOHSCT IN PATIENTS ≥65 YEARS: A GETH-TC STUDY

EHA Library, Sara Fernandez-Luis, 4207022

IMMUNE RECONSTITUTION AFTER HAPLO-IDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANT: A PROSPECTIVE REAL-WORLD STUDY

EHA Library, Himani Gupta, 4207024

EFFICACY OF LOW-DOSE ATG COMBINED WITH PTCY IN CHILDREN WITH CHRONIC GRANULOMATOUS DISEASE UNDERGOING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yingjian Si, 4207027

MYELOABLATIVE FRACTIONATED BUSULFAN, FLUDARABINE, CLADRIBINE, THIOTEPA, AND VENETOCLAX (CLADILLAC) CONDITIONING FOR HIGH-RISK AML: A PHASE 2 TRIAL

EHA Library, Uday R. Popat, 4207028

LONGITUDINAL TCR SEQUENCING REVEALS DONOR-DEPENDENT IMMUNE RECONSTITUTION PATTERNS AFTER PEDIATRIC ALLOGENEIC HSCT FOR PRIMARY IMMUNODEFICIENCIES

EHA Library, Guanghua Zhu, 4207030

DONOR-DERIVED CYTOGENETIC ALTERATIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER COHORT STUDY

EHA Library, Corinne Widmer, 4207031

A MOLECULAR-BASED RISK SCORE FOR PREDICTING LEUKEMIA-FREE SURVIVAL IN ADULT AML PATIENTS UNDERGOING ALLO-HSCT

EHA Library, Shuang Li, 4207032

ALLOGENEIC STEM CELL TRANSPLANTATION FOR SECONDARY HEMATOLOGIC MALIGNANCIES ARISING FROM PLASMA CELL NEOPLASM

EHA Library, Masaya Maegaki, 4207036

LONGITUDINAL ASSESSMENT OF COMPLEMENT FACTOR BA AND CLINICAL RESPONSE IN ADULT TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Min Wu, 4207037

TRANSPLANTATION STRATEGIES FOR LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-A MULTICENTER, REALWORLD STUDY

EHA Library, Jiexian Ma, 4207038

IMPACT OF RECIPIENT AGE ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: AN ANALYSIS FROM THE CHINESE BONE MARROW TRANSPLANT REGISTRY GROUP (CBMTRG)

EHA Library, Xiaoli Liang, 4207039

A PROSPECTIVE COHORT STUDY: THE ASSOCIATION BETWEEN NUTRITIONAL STATUS OF HSCT PATIENTS BEFORE TRANSPLANTATION AND EARLY INFECTION AND NON-RELAPSE MORTALITY

EHA Library, Weiwei Qin, 4207041

PIRCHE SCORES AND RECIPIENT HLA-B LEADER INFLUENCE RELAPSE AND CHRONIC GVHD AFTER 9/10 UNRELATED DONOR ALLO-HCT WITH CLASS I MISMATCH

EHA Library, Rodrigo Gil Manso, 4207043

ADENOVIRUS INFECTION AFTER ALLO-HSCT: PERSISTENT VIRAL POSITIVITY INDICATES T-CELL DYSFUNCTION AND PREDICTS POOR OUTCOME

EHA Library, Zhihui Li, 4207044

DEEP LEARNING–BASED PREDICTION OF CD34⁺ CELL MOBILIZATION IN HEALTHY DONORS: AN EXPLAINABLE ARTIFICIAL NEURAL NETWORK MODEL WITH SUPERIOR PREDICTIVE PERFORMANCE

EHA Library, Bedrettin Orhan, 4207046

INTEGRATING DONOR CHIMERISM IN MACHINE LEARNING MODELS FOR DISEASE RELAPSE PREDICTION FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Ray Mun Koo, 4207049

HEMATOPOIETIC STEM CELL TRANSPLANTATION AND LATENT TUBERCULOSIS INFECTION

EHA Library, Ana Pilar Gonzalez Rodríguez, 4207050

SECONDARY MALIGNANCIES FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIA: A SINGLE-CENTER EXPERIENCE

EHA Library, Malek Benakli, 4207052

KANGFUXIN COMBINED WITH G-CSF ICE-CUBE CRYOTHERAPY EFFECTIVELY PREVENTS THIOTEPA-BASED CONDITIONING–INDUCED ORAL MUCOSITIS IN ALLOGENEIC HSCT: A PROSPECTIVE OPEN-LABEL COHORT STUDY

EHA Library, Li Wang, 4207054

IMMUNE RECONSTITUTION KINETICS AND CLINICAL OUTCOMES AFTER ALLOGENEIC HSCT FOR CHRONIC MYELOMONOCYTIC LEUKEMIA: A MATCHED VERSUS HAPLOIDENTICAL DONOR COMPARISON

EHA Library, Mengtong Zang, 4207056

UMBILICAL CORD BLOOD MONONUCLEAR CELL INFUSION FOR SECONDARY POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PHASE I DOSE-ESCALATION STUDY

EHA Library, Yigeng Cao, 4207057

COMPARISON OF TOTAL BODY IRRADIATION (TBI) AND NON-TBI CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH PRIMARY MYELOFIBROSIS

EHA Library, mingzhe Han, 4207058